Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successfuI treatment
- 1 January 1993
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 38 (1) , 73-78
- https://doi.org/10.1111/j.1365-2265.1993.tb00975.x
Abstract
We tested the hypothesis that in Cushing's disease, ACTH secretion from the normal pituitary surrounding an ACTH-secreting adenoma is inhibited and hence removal of the entire adenoma should result in an undetectable serum cortisol in the immediate post-operative period. A retrospective study of patients undergoing transsphenoidal selective adenomectomy, hemi-hypophysectomy or total hypophysectomy for Cushing's disease at St Bartholomew's Hospital between 1985 and 1990. Forty-eight consecutive patients (33 women, mean age 43, range 7-69 years) undergoing transsphenoidal hypophysectomy for Cushing's disease. Ten patients who underwent a second operation were re-evaluated; the patients were followed for a median time of 40 months after operation (range 15-70). Post-operatively, serum cortisol was measured daily at 0900 h. Serum TSH, T4, prolactin, LH, FSH, testosterone or oestradiol plus plasma and urine osmolality were measured. After initial surgery, post-operative serum cortisol was undetectable (< 50 nmol/l) in 20 out of 48 patients (42%) and < 300 nmol/l in 32 out of 48 patients (67%). Re-exploration of the pituitary fossa in 10 patients found undetectable cortisol levels in 25 (52%) and levels < 300 nmol/l in 39 (81%) patients. Cushing's syndrome has not recurred, clinically or biochemically, in any patient in whom the post-operative cortisol was < 50 nmol/l. Post-operatively, hypothyroidism was present in 40% of patients and hypogonadism in 53% of men and 30% of premenopausal women. Diabetes insipidus, persisting for at least six months, occurred in 46% of patients. Cushing's disease has not recurred in any patient with an undetectable serum cortisol (< 50 nmol/l) post-operatively. Serum cortisol should be regarded as a tumour marker in Cushing's disease and the aim of transsphenoidal hypophysectomy for Cushing's disease should be to render the immediate post-operative serum cortisol undetectable.Keywords
This publication has 22 references indexed in Scilit:
- Short and long‐term responses to metyrapone in the medical management of 91 patients with Cushing's syndromeClinical Endocrinology, 1991
- The treatment of Cushing's syndromeClinical Endocrinology, 1991
- TRANSSPHENOIDAL SURGERY FOR CUSHING'S DISEASE: DOES WHAT IS REMOVED DETERMINE THE ENDOCRINE OUTCOME?Clinical Endocrinology, 1990
- Cushing's syndrome difficulties in diagnosisTrends in Endocrinology & Metabolism, 1990
- Repeat transsphenoidal surgery for Cushing's diseaseJournal of Neurosurgery, 1989
- Cushing's disease. A reviewArchives of internal medicine (1960), 1985
- TRANSSPHENOIDAL MICROSURGERY FOR CUSHING'S DISEASEClinical Endocrinology, 1984
- Transsphenoidal microsurgical management of Cushing's diseaseJournal of Neurosurgery, 1983
- Pituitary cushing's syndrome and nelson's syndrome: Diagnostic criteria, surgical therapy, and resultsSurgical Neurology, 1981
- Recurrence after a surgically induced remissionArchives of internal medicine (1960), 1979